Nocardia is a genus of gram-positive, partially acid-fast bacilli that typically infect people with chronic lung disease or immunocompromised states. Nocardia most commonly affects the lungs or skin but has the potential to disseminate to essentially any anatomic site, such as the brain. Due to ...
Editor's Choice
The prevalence of Kaposi Sarcoma-associated herpesvirus (KSHV) was high among kidney donor and transplant recipients with HIV. Post-transplant KSHV-associated disease incidence was similar to that observed in endemic countries but disease was generally mild and attributed to recipient KSHV.
Nocardia is a genus of gram-positive, partially acid-fast bacilli that typically infect people with chronic lung disease or immunocompromised states. Nocardia most commonly affects the lungs or skin but has the potential to disseminate to essentially any anatomic site, such as the brain. Due to variability in ...
Nocardiosis is an uncommon yet potentially devastating infection. Nocardia tends to affect individuals with chronic lung disease or immunocompromising conditions, 2 groups increasing in number. Incidence of nocardiosis is likely to increase as well, and it is vital to have an approach to this complex disease. Here, we aim ...
This study elaborates on transmitted drug resistance (TDR) among antiretroviral therapy–naive people newly diagnosed with HIV in China. It was found that the TDR among people with newly diagnosed HIV exceeds 10%, notably with TDR of >5% to efavirenz/nevirapine.
Photo Quizzes
CID regularly publishes question-and-answer challenges that illustrate unusual illnesses and that invite diagnoses from readers. Browse all photo quiz papers online today.
Read now
New article series on TB Isolation
Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID) have partnered to publish a new article series on TB Isolation. This series, developed in response to the new guidelines from National Tuberculosis Coalition of America, offers essential perspectives for clinicians, researchers, and public health professionals.
Read now
CID Now Offers Review Pathway for Papers Rejected by High-Impact Journals
Clinical Infectious Diseases welcomes papers that have been peer reviewed by another medical journal and were not accepted for publication, where the authors believe they can address the essential concerns identified by previous reviewers. Under this new pathway, authors can revise the paper according to the review comments they previously received and then submit the paper to CID. This new pathway is intended to speed publication and minimize unnecessary re-review of papers that previously received thorough and detailed review elsewhere.
Learn more about how to submit using this pathway.
2024 Reviewer of the Year Recipients
The IDSA journals congratulate the 2024 Reviewer of the Year awardees for their excellence in completing peer reviews for IDSA’s three journals. CID's 2024 recipients are Anna Lok, MD; Cesar G. Berto, MD; and David Paterson, MD, PhD. Reviewers were selected through IDSA’s reviewer recognition and rewards program.
CID is now on Bluesky!
We are excited to announce that Clinical Infectious Diseases now has an official presence on Bluesky! Follow us for the latest updates, research highlights, and more to stay connected with cutting-edge developments in infectious diseases.
Find us at @cidjournal.bsky.social
Recent Supplements
